Studies on the metabolism of haloperidol (HP): The role of CYP3A in the production of the neurotoxic pyridinium metabolite HPP+ found in rat brain following ip administration of HP
Authors:
- F. KasuyaFKF. Kasuya
- M. FukuiMFM. Fukui
- 1 November 1995
- journal article
- Published by Elsevier in Life Sciences
- Vol. 57 (26) , 2439-2446
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Determination of the pyridinium metabolite derived from haloperidol in brain tissue, plasma and urine by high-performance liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary cultureThe FASEB Journal, 1992
- Identification of potentially neurotoxic pyridinium metabolite in the urine of schizophrenic patients treated with haloperidolBiochemical and Biophysical Research Communications, 1991
- Dehydration is the first step in the bioactivation of haloperidol to its pyridinium metaboliteToxicology Letters, 1991
- Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metaboliteChemical Research in Toxicology, 1991
- Regional and subcellular distribution of cytochrome P-450-dependent drug metabolism in monkey brain: The olfactory bulb and the mitochondrial fraction have high levels of activityBiochemical and Biophysical Research Communications, 1990
- Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in ratsBiochemical and Biophysical Research Communications, 1990
- The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in manBiochemical Pharmacology, 1989
- Tardive dyskinesiaActa Psychiatrica Scandinavica, 1988
- Isolation and Identification of a Metabolite of HaloperidolJournal of Analytical Toxicology, 1981